Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease.

about

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease.

Item

http://www.wikidata.org/entity/Q47098894

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@en

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@nl

type

Item

label

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@en

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@nl

prefLabel

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@en

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@nl

P1476

Glyco-sphingo biology: a novel ...... ments in Huntington's disease.

@en

P2093

Alba Di Pardo

http://www.w3.org/2001/XMLSchema#string

Vittorio Maglione

http://www.w3.org/2001/XMLSchema#string

P2860

Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.

Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex.

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.

Sphingosine-1-phosphate signaling and its role in disease.

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

Molecular mechanisms and potential therapeutical targets in Huntington's disease.

To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

P304

1439-1440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.215253

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alba Di Pardo

Vittorio Maglione

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29089987

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5649462

http://www.w3.org/2001/XMLSchema#string